Bryan Smith
Advanced Heart Failure and Transplant Cardiology · Chicago, ILNPI 1982914990
Payments from drug & device makers
What this record shows
23 manufacturers reported payments, led by Pfizer at 56.5% of the total. Reporting peaked in 2022 at $5,491 and has fallen 99.1% since, to $50 in 2025. That places this record below the midpoint for advanced heart failure and transplant cardiology clinicians in IL, where the typical reported total is $11,038.
Across 118 payments — averaging $72.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$5K
- Abbott$2K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$494
- Medtronic$183
- Cvrx, Inc.$171
- Novo Nordisk$117
- plus $510 from 17 others
What the payments were for
- Speaking & faculty fees$4,70055%
- Food & beverage$3,87945%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 8 | $4,844 |
| Abbott | 54 | $2,260 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 26 | $494 |
| Medtronic | 3 | $183 |
| Cvrx, Inc. | 1 | $171 |
| Novo Nordisk | 1 | $117 |
| Novartis | 4 | $67 |
| AstraZeneca | 3 | $56 |
| Amgen | 2 | $47 |
| Boehringer Ingelheim | 2 | $35 |
| ZOLL Circulation Inc | 1 | $35 |
| E.r. Squibb & Sons, L.L.C. | 2 | $34 |
| Bridgebio Pharma, Inc. | 1 | $29 |
| Portola Pharmaceuticals, LLC | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| United Therapeutics Corporation | 1 | $22 |
| Akcea Therapeutics, Inc. | 1 | $21 |
| Lantheus Medical Imaging, Inc. | 1 | $21 |
| Merck | 1 | $21 |
| Kerecis Limited | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,579 in reported general payments places this provider in the 40th percentile of 56 advanced heart failure and transplant cardiology providers in Illinois.
See all advanced heart failure and transplant cardiology providers in Illinois →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 11 | $224 |
| Spironolactone | 20 | $213 |
| Carvedilol | 14 | $70 |
Paid to pharmacies, not to this prescriber.
Other advanced heart failure and transplant cardiology in Chicago
- Jonathan RichChicago$327K
- Esther VorovichChicago$224K
- Jane WilcoxChicago$220K
- Manreet KanwarChicago$162K
- Jonathan GrinsteinChicago$128K
- Bow ChungChicago$86K
- Quentin YoumansChicago$75K
- Anjan TibrewalaChicago$58K
- Faraz AhmadChicago$36K
- Ike OkwuosaChicago$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.